Eun-Mi Kim Selected Research

Peptides (Polypeptides)

11/2013	Nonpolymeric surface-coated iron oxide nanoparticles for in vivo molecular imaging: biodegradation, biocompatibility, and multiplatform.
10/2012	Optical imaging of MMP expression and cancer progression in an inflammation-induced colon cancer model.
8/2012	F-18 labeling protocol of peptides based on chemically orthogonal strain-promoted cycloaddition under physiologically friendly reaction conditions.
8/2011	Iodine 125-labeled mesenchymal-epithelial transition factor binding peptide-click-cRGDyk heterodimer for glioma imaging.
7/2010	Synthesis of Tc-99m labeled 1,2,3-triazole-4-yl c-met binding peptide as a potential c-met receptor kinase positive tumor imaging agent.
5/2009	Characterization, biodistribution and small-animal SPECT of I-125-labeled c-Met binding peptide in mice bearing c-Met receptor tyrosine kinase-positive tumor xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eun-Mi Kim Research Topics

Disease

34	Neoplasms (Cancer) 10/2023 - 06/2002
8	Inflammation (Inflammations) 01/2022 - 09/2007
4	Infections 01/2020 - 07/2003
4	Colorectal Neoplasms (Colorectal Cancer) 09/2019 - 10/2012
4	Neoplasm Metastasis (Metastasis) 12/2017 - 06/2002
3	Melanoma (Melanoma, Malignant) 01/2018 - 03/2006
3	Carcinogenesis 01/2017 - 08/2012
3	Glioma (Gliomas) 08/2011 - 05/2009
2	Respiratory Syncytial Virus Infections 12/2022 - 01/2022
2	Body Weight (Weight, Body) 07/2019 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 10/2012
1	Chemical and Drug Induced Liver Injury 05/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2023
1	Starvation 01/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2022
1	Babesiosis (Piroplasmosis) 01/2022
1	Mast-Cell Leukemia (Leukemia, Mast Cell) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2021
1	Osteitis 01/2021
1	Tendinopathy (Tendonitis) 11/2020
1	Shoulder Pain 11/2020
1	Osteoporosis 10/2020
1	Herpes Zoster 10/2020
1	Colitis 07/2019

Drug/Important Bio-Agent (IBA)

6	Peptides (Polypeptides)IBA 11/2013 - 05/2009
5	Proteins (Proteins, Gene)FDA Link 09/2019 - 06/2002
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2005
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2017 - 05/2009
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2012 - 03/2010
3	Transferrin (beta 2 Transferrin)IBA 12/2008 - 10/2004
2	CytokinesIBA 05/2024 - 07/2003
2	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 11/2005
2	Liposomes (Liposome)IBA 01/2021 - 04/2016
2	CateninsIBA 09/2019 - 01/2015
2	Therapeutic UsesIBA 07/2019 - 04/2016
2	Radioisotopes (Radionuclides)IBA 01/2018 - 10/2004
2	gluconic acid (gluconate)FDA LinkGeneric 01/2018 - 11/2013
2	LigandsIBA 03/2017 - 05/2009
2	Lymphotoxin-alpha (Lymphotoxin)IBA 03/2017 - 06/2011
2	Adenosine Triphosphate (ATP)IBA 11/2013 - 03/2006
2	BombesinIBA 08/2012 - 04/2010
2	sodium-iodide symporter (sodium iodide symporter)IBA 12/2011 - 01/2011
2	Amino Acids FDA Link 08/2011 - 05/2009
2	Histidine (L-Histidine)FDA Link 08/2011 - 04/2010
2	ChitosanIBA 02/2011 - 11/2007
2	RadiopharmaceuticalsIBA 12/2010 - 10/2004
2	Coloring Agents (Dyes)IBA 07/2009 - 10/2004
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 05/2009 - 11/2005
2	Formaldehyde (Formol)FDA Link 09/2007 - 08/2007
1	RNA Precursors (Precursor, mRNA)IBA 10/2023
1	RNA Splicing FactorsIBA 10/2023
1	Protein Isoforms (Isoforms)IBA 10/2023
1	AntioxidantsIBA 03/2023
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Particulate MatterIBA 12/2022
1	polyhexamethyleneguanidineIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Disinfectants (Biocides)IBA 01/2022
1	Hexosaminidases (Hexosaminidase)IBA 01/2022
1	18S Ribosomal RNAIBA 01/2022
1	oxidized low density lipoproteinIBA 02/2021
1	LDL CholesterolIBA 02/2021
1	Cell Surface ReceptorsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Durapatite (Hydroxylapatite)IBA 11/2020
1	Tight Junction ProteinsIBA 10/2020
1	MagnesiumIBA 10/2020
1	Alkaline PhosphataseIBA 10/2020
1	Collagenases (Collagenase)FDA Link 06/2020
1	Technetium Tc 99m Exametazime (Ceretec)FDA Link 01/2020
1	Biomarkers (Surrogate Marker)IBA 09/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2019
1	Cyclin D1IBA 09/2019
1	lyonisideIBA 07/2019
1	Dextran SulfateIBA 07/2019
1	Immunoglobulin A (IgA)IBA 07/2019
1	AcidsIBA 03/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2018
1	Melanins (Melanin)IBA 01/2018
1	NAD (NADH)IBA 01/2018
1	Glucosamine (Dona)IBA 01/2018
1	ferric oxyhydroxideIBA 01/2018
1	MonosaccharidesIBA 01/2018
1	LuciferasesIBA 12/2017
1	p38 Mitogen-Activated Protein KinasesIBA 12/2017
1	SB 203580IBA 12/2017
1	Member 14 Tumor Necrosis Factor ReceptorsIBA 03/2017
1	Glycoproteins (Glycoprotein)IBA 03/2017

Therapy/Procedure

9	Therapeutics 01/2023 - 10/2004
3	Aftercare (After-Treatment) 02/2015 - 03/2006
2	Drug Therapy (Chemotherapy) 10/2021 - 04/2016
2	Gamma Cameras (Gamma Camera) 01/2018 - 11/2007
2	Lasers (Laser) 12/2017 - 03/2006
2	Intravenous Injections 10/2012 - 02/2011
1	Humidifiers 01/2022
1	Immunotherapy 12/2021